Five questions to better understand T-cell receptors therapy
T-Cell receptors therapy is a growing area of immuno-oncology with recent breakthroughs in clinical settings, thereby demonstrating his therapeutic potential in mitigating tumor development. So what do you know about T-Cell therapy? Read on! Dr. Erika von Euw from T-Cure Bioscience help us to understand it better.
Research Roundup: cell biology
Do you love cell biology? Here for you are three new research studies showing our antibodies in action. This latest Research Roundup talks about kinesin’s motor domain in microtubules, membranes & trafficking in organelles, and lysosomal protein composition.
Research Roundup: stem cell research
Want to see our antibodies in action? Keep reading our latest Research Roundup! The following three studies have successfully utilized Atlas Antibodies products in stem cell research.
Ion channels as promising biomarkers in cancer
In this blog post, we share bits of evidence about the involvement of voltage-gated ion channels in human cancers, highlighting their promising use as biomarkers. Read on!
Research Roundup: diagnostic and prognostic cancer markers
Are you interested in seeing more of our antibodies in action? The following three studies have successfully utilized our antibodies to suggest or identify new biomarkers for different human cancers. Keep reading.
Research Roundup: see our neuroscience products in action
Our antibodies are used in cutting-edge neuroscience research around the world. Let's take a look at three recent studies showing our antibodies in action.
Interview with a scientist: proteomics, biomarkers and ALS.
No effective therapies are currently available for Amyotrophic Lateral Sclerosis- ALS due to the lack of biomarkers for early diagnosis and monitoring disease progression. Dr. Valentina Bonetto applies proteomic assays to find validated biomarkers and innovative therapeutic strategies to treat ALS.
Research Roundup: neuroscience antibodies and protein standards
Our highly-validated antibodies and QPrEST protein standards are used in cutting-edge neuroscience research. Read a roundup of some newly published studies to see our neuroscience antibodies and targeted proteomics in action!
Research Roundup: prognostic biomarkers in cancer
Many of our cancer antibodies are used in cutting-edge research to identify new prognostic markers in different cancers. Let's take a look at three recent studies.
Now I see you: the imaging toolbox that improves the detection of primary ciliary dyskinesia
Ciliopathies are inherited human disorders that affect primary cilia genes. The authors of this study took part in our Explorer Program. Read on to discover what they found.